GSK: Zantac settlements hit profit but guidance unchanged
Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed ...
Drugmaker GSK Posts Loss On Zantac Fallout
British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.
pharmaphorum1d
GSK, Sanofi and Haleon 'facing billions of dollars in Zantac liability'
Zantac was originated by GSK and launched by ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...
GSK shares jump on $2.2 billion Zantac settlement
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.
pharmaphorum3d
GSK shares dive on Zantac court case ruling
The new 102-page opinion contradicts a December 2022 federal court ruling which dismissed all cases alleging five cancer types. The complaints revolve around allegations that Zantac and other ...
Orange County Register1mon
GSK to settle 80,000 Zantac cases for up to $2.2 billion
GSK’s American depositary receipts rose as much as 9.9% in New York after the agreement was announced. GSK is among a number of companies that made and sold versions of Zantac, and investor ...
Nasdaq1mon
GSK Reaches $2.2 Bln Settlement Over Zantac Liability Cases
Additionally, GSK has reached an agreement in principle to pay a total of $70 million to settle a Zantac qui tam complaint ... 1990s by Andrew Mariathasan in New York, with the goal of covering ...